ROTHSCHILD & CO ASSET MANAGEMENT US INC. – Ultragenyx Pharmaceutical Inc. Transaction History
ROTHSCHILD & CO ASSET MANAGEMENT US INC. portfolio value:
$4.99M
portfolio value
ROTHSCHILD & CO ASSET MANAGEMENT US INC. quarter portfolio value change:
-30.59%
quarter
Ultragenyx Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +145.39% | 71.49K shares | 2.06M | $41.41 | 120.66K |
| Q2 2022 | share | Increase | +11.97% | 5.25K shares | -255K | $59.66 | 49.17K |
| Q1 2022 | share | Increase | 0.00% | 43.91K shares | 3.18M | $72.62 | 43.91K |
| Q3 2020 | share | Decrease | -100.00% | -125.68K shares | -9.83M | $82.19 | 0 |
| Q2 2020 | share | Decrease | -11.41% | -16.18K shares | 3.52M | $78.22 | 125.68K |
| Q1 2020 | share | Decrease | -10.88% | -17.31K shares | -496K | $44.43 | 141.87K |
| Q4 2019 | share | Increase | +47.95% | 51.59K shares | 2.19M | $42.71 | 159.18K |
| Q3 2019 | share | Increase | +2.20% | 2.31K shares | -2.08M | $42.78 | 107.59K |
| Q2 2019 | share | Increase | +89.55% | 49.73K shares | 2.83M | $63.5 | 105.27K |
| Q1 2019 | share | Increase | +93.92% | 26.89K shares | 2.60M | $69.36 | 55.54K |
| Q4 2018 | share | Decrease | -0.92% | -266 shares | -962K | $43.48 | 28.64K |
| Q3 2018 | share | Increase | 0.00% | 28.90K shares | 2.20M | $76.34 | 28.90K |
| Q2 2018 | share | Increase | +25.78% | 5.99K shares | 1.06M | $76.87 | 29.26K |
| Q1 2018 | share | Decrease | -7.57% | -1.90K shares | 18K | $50.99 | 23.26K |
| Q4 2017 | share | Decrease | -6.96% | -1.88K shares | -273K | $46.38 | 25.17K |
| Q3 2017 | share | Decrease | -1.37% | -377 shares | -263K | $53.26 | 27.05K |
| Q2 2017 | share | Decrease | -5.01% | -1.44K shares | -254K | $62.11 | 27.43K |
| Q1 2017 | share | Decrease | -6.84% | -2.12K shares | -222K | $67.78 | 28.88K |
| Q4 2016 | share | Increase | +453.64% | 25.40K shares | 1.78M | $70.31 | 31.00K |
| Q3 2016 | share | Increase | +17.40% | 830 shares | 164K | $70.94 | 5.6K |
| Q2 2016 | share | Increase | 0.00% | 4.77K shares | 233K | $48.91 | 4.77K |